Table 2. Data at recurrence.
Patient | 1 | 2 | 3 | 4 | 5 | 6 | 7 |
Second tx adjuvants | Carboplatin Bevacizumab | Pembrolizumab Bevacizumab | None | Lomustin | None | None | None |
Extent of resection | GTR | STR | GTR | STR | STR | GTR | GTR |
GCS Preop/Postop | 15/15 | 15/14 | 15/13 | 15/14 | 15/14 | 15/15 | 15/14 |
ICU/ hospital LOS | 1/2 | 2/2 | 4/8 | 1/7 | 1/11 | 1/3 | 2/4 |
Disposition | Home | Home | Rehab | Rehab | Rehab | Home | Home |
Subsequent recurrence | Yes | Yes | Maybe | Yes | No | Maybe | Unknown |
Complications | None | None | Significant postop edema, requiring additional Decadron® and 3% NaCl | Expressive aphasia | L hemiparesis | None | None |
Radiation necrosis | None | None | None | None | None | None | Unknown |